Cargando…
PTCOG Head and Neck Subcommittee Consensus Guidelines on Particle Therapy for the Management of Head and Neck Tumors
PURPOSE: Radiation therapy is a standard modality in the treatment for cancers of the head and neck, but is associated with significant short- and long-term side effects. Proton therapy, with its unique physical characteristics, can deliver less dose to normal tissues, resulting in fewer side effect...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Particle Therapy Co-operative Group
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8270078/ https://www.ncbi.nlm.nih.gov/pubmed/34285938 http://dx.doi.org/10.14338/IJPT-20-00071.1 |
_version_ | 1783720724456800256 |
---|---|
author | Lin, Alexander Chang, John H. C. Grover, Ryan S. Hoebers, Frank J. P. Parvathaneni, Upendra Patel, Samir H. Thariat, Juliette Thomson, David J. Langendijk, Johannes A. Frank, Steven J. |
author_facet | Lin, Alexander Chang, John H. C. Grover, Ryan S. Hoebers, Frank J. P. Parvathaneni, Upendra Patel, Samir H. Thariat, Juliette Thomson, David J. Langendijk, Johannes A. Frank, Steven J. |
author_sort | Lin, Alexander |
collection | PubMed |
description | PURPOSE: Radiation therapy is a standard modality in the treatment for cancers of the head and neck, but is associated with significant short- and long-term side effects. Proton therapy, with its unique physical characteristics, can deliver less dose to normal tissues, resulting in fewer side effects. Proton therapy is currently being used for the treatment of head and neck cancer, with increasing clinical evidence supporting its use. However, barriers to wider adoption include access, cost, and the need for higher-level evidence. METHODS: The clinical evidence for the use of proton therapy in the treatment of head and neck cancer are reviewed here, including indications, advantages, and challenges. RESULTS: The Particle Therapy Cooperative Group Head and Neck Subcommittee task group provides consensus guidelines for the use of proton therapy for head and neck cancer. CONCLUSION: This report can be used as a guide for clinical use, to understand clinical trials, and to inform future research efforts. |
format | Online Article Text |
id | pubmed-8270078 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | The Particle Therapy Co-operative Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-82700782021-07-19 PTCOG Head and Neck Subcommittee Consensus Guidelines on Particle Therapy for the Management of Head and Neck Tumors Lin, Alexander Chang, John H. C. Grover, Ryan S. Hoebers, Frank J. P. Parvathaneni, Upendra Patel, Samir H. Thariat, Juliette Thomson, David J. Langendijk, Johannes A. Frank, Steven J. Int J Part Ther Clinical PURPOSE: Radiation therapy is a standard modality in the treatment for cancers of the head and neck, but is associated with significant short- and long-term side effects. Proton therapy, with its unique physical characteristics, can deliver less dose to normal tissues, resulting in fewer side effects. Proton therapy is currently being used for the treatment of head and neck cancer, with increasing clinical evidence supporting its use. However, barriers to wider adoption include access, cost, and the need for higher-level evidence. METHODS: The clinical evidence for the use of proton therapy in the treatment of head and neck cancer are reviewed here, including indications, advantages, and challenges. RESULTS: The Particle Therapy Cooperative Group Head and Neck Subcommittee task group provides consensus guidelines for the use of proton therapy for head and neck cancer. CONCLUSION: This report can be used as a guide for clinical use, to understand clinical trials, and to inform future research efforts. The Particle Therapy Co-operative Group 2021-06-25 /pmc/articles/PMC8270078/ /pubmed/34285938 http://dx.doi.org/10.14338/IJPT-20-00071.1 Text en ©Copyright 2021 The Author(s) 2020 https://creativecommons.org/licenses/by/4.0/Distributed under Creative Commons CC-BY (https://creativecommons.org/licenses/by/4.0/) |
spellingShingle | Clinical Lin, Alexander Chang, John H. C. Grover, Ryan S. Hoebers, Frank J. P. Parvathaneni, Upendra Patel, Samir H. Thariat, Juliette Thomson, David J. Langendijk, Johannes A. Frank, Steven J. PTCOG Head and Neck Subcommittee Consensus Guidelines on Particle Therapy for the Management of Head and Neck Tumors |
title | PTCOG Head and Neck Subcommittee Consensus Guidelines on Particle Therapy for the Management of Head and Neck Tumors |
title_full | PTCOG Head and Neck Subcommittee Consensus Guidelines on Particle Therapy for the Management of Head and Neck Tumors |
title_fullStr | PTCOG Head and Neck Subcommittee Consensus Guidelines on Particle Therapy for the Management of Head and Neck Tumors |
title_full_unstemmed | PTCOG Head and Neck Subcommittee Consensus Guidelines on Particle Therapy for the Management of Head and Neck Tumors |
title_short | PTCOG Head and Neck Subcommittee Consensus Guidelines on Particle Therapy for the Management of Head and Neck Tumors |
title_sort | ptcog head and neck subcommittee consensus guidelines on particle therapy for the management of head and neck tumors |
topic | Clinical |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8270078/ https://www.ncbi.nlm.nih.gov/pubmed/34285938 http://dx.doi.org/10.14338/IJPT-20-00071.1 |
work_keys_str_mv | AT linalexander ptcogheadandnecksubcommitteeconsensusguidelinesonparticletherapyforthemanagementofheadandnecktumors AT changjohnhc ptcogheadandnecksubcommitteeconsensusguidelinesonparticletherapyforthemanagementofheadandnecktumors AT groverryans ptcogheadandnecksubcommitteeconsensusguidelinesonparticletherapyforthemanagementofheadandnecktumors AT hoebersfrankjp ptcogheadandnecksubcommitteeconsensusguidelinesonparticletherapyforthemanagementofheadandnecktumors AT parvathaneniupendra ptcogheadandnecksubcommitteeconsensusguidelinesonparticletherapyforthemanagementofheadandnecktumors AT patelsamirh ptcogheadandnecksubcommitteeconsensusguidelinesonparticletherapyforthemanagementofheadandnecktumors AT thariatjuliette ptcogheadandnecksubcommitteeconsensusguidelinesonparticletherapyforthemanagementofheadandnecktumors AT thomsondavidj ptcogheadandnecksubcommitteeconsensusguidelinesonparticletherapyforthemanagementofheadandnecktumors AT langendijkjohannesa ptcogheadandnecksubcommitteeconsensusguidelinesonparticletherapyforthemanagementofheadandnecktumors AT frankstevenj ptcogheadandnecksubcommitteeconsensusguidelinesonparticletherapyforthemanagementofheadandnecktumors |